Annual Retained Earnings
-$9.78 M
-$134.41 M-107.85%
December 31, 2024
Summary
- As of March 8, 2025, ITOS annual retained earnings is -$9.78 million, with the most recent change of -$134.41 million (-107.85%) on December 31, 2024.
- During the last 3 years, ITOS annual retained earnings has fallen by -$150.40 million (-106.96%).
- ITOS annual retained earnings is now -104.12% below its all-time high of $237.28 million, reached on December 31, 2022.
Performance
ITOS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$9.78 M
-$43.71 M-128.83%
December 31, 2024
Summary
- As of March 8, 2025, ITOS quarterly retained earnings is -$9.78 million, with the most recent change of -$43.71 million (-128.83%) on December 31, 2024.
- Over the past year, ITOS quarterly retained earnings has dropped by -$43.71 million (-128.83%).
- ITOS quarterly retained earnings is now -104.12% below its all-time high of $237.28 million, reached on December 31, 2022.
Performance
ITOS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ITOS Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -107.8% | -128.8% |
3 y3 years | -107.0% | -107.0% |
5 y5 years | +72.7% | +72.7% |
ITOS Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -104.1% | at low | -104.1% | at low |
5 y | 5-year | -104.1% | +86.8% | -104.1% | +91.4% |
alltime | all time | -104.1% | +86.8% | -104.1% | +91.4% |
ITeos Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$9.78 M(-107.8%) | -$9.78 M(-128.8%) |
Sep 2024 | - | $33.93 M(-57.2%) |
Jun 2024 | - | $79.29 M(-8.2%) |
Mar 2024 | - | $86.42 M(-30.7%) |
Dec 2023 | $124.63 M(-47.5%) | $124.63 M(-19.7%) |
Sep 2023 | - | $155.18 M(-17.2%) |
Jun 2023 | - | $187.42 M(-15.5%) |
Mar 2023 | - | $221.72 M(-6.6%) |
Dec 2022 | $237.28 M | $237.28 M(+9.4%) |
Sep 2022 | - | $216.82 M(+0.5%) |
Jun 2022 | - | $215.83 M(+2.7%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $210.21 M(+49.5%) |
Dec 2021 | $140.62 M(-290.3%) | $140.62 M(-417.8%) |
Sep 2021 | - | -$44.25 M(-61.1%) |
Jun 2021 | - | -$113.89 M(+30.3%) |
Mar 2021 | - | -$87.43 M(+18.3%) |
Dec 2020 | -$73.90 M(+106.0%) | -$73.90 M(+25.3%) |
Sep 2020 | - | -$58.99 M(+22.1%) |
Jun 2020 | - | -$48.31 M(+17.5%) |
Mar 2020 | - | -$41.11 M(+14.6%) |
Dec 2019 | -$35.87 M(+233.2%) | -$35.87 M |
Dec 2018 | -$10.77 M | - |
FAQ
- What is iTeos Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for iTeos Therapeutics?
- What is iTeos Therapeutics annual retained earnings year-on-year change?
- What is iTeos Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly retained earnings year-on-year change?
What is iTeos Therapeutics annual retained earnings?
The current annual retained earnings of ITOS is -$9.78 M
What is the all time high annual retained earnings for iTeos Therapeutics?
iTeos Therapeutics all-time high annual retained earnings is $237.28 M
What is iTeos Therapeutics annual retained earnings year-on-year change?
Over the past year, ITOS annual retained earnings has changed by -$134.41 M (-107.85%)
What is iTeos Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ITOS is -$9.78 M
What is the all time high quarterly retained earnings for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly retained earnings is $237.28 M
What is iTeos Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ITOS quarterly retained earnings has changed by -$43.71 M (-128.83%)